Contract facts
NONENo full NAICS 334516 intel page yet. Browse NAICS intelligence
MISEQ REAGENT KIT V2 is a federal NONE award for Army Med Res Acq Activity held by Verogen, Inc. Estimated value $176K ($176K obligated). Current period of performance ends Jun 11, 2024. Last award drew 1 bidder. Place of performance: SAN DIEGO CA.
Recompete timing
PublicCurrent PoP ended Jun 11, 2024 (801 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942524F0194?
HT942524F0194 (MISEQ reagent KIT v2) is a Army Med Res Acq Activity award with a potential value of $176K, currently held by Verogen, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-24-F-0194?
HT9425-24-F-0194 is the dashed form of PIID HT942524F0194 (MISEQ reagent KIT v2), held by Verogen, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942524F0194?
Army Med Res Acq Activity awarded HT942524F0194 to Verogen, Inc (potential $176K).
Who is the incumbent on HT942524F0194?
Verogen, Inc is the incumbent. The current period of performance ends Jun 11, 2024.
When does Verogen, Inc’s HT942524F0194 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 11, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.